A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme's teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif).
联系方式:13396289785
主营产品:(2,4-二氯苄基)三苯基氯化鏻 乙氧甲酰基乙基三苯基溴化鏻 5-羧戊基三苯基溴化鏻 甲基三苯基碘化鏻 三(1-萘基)膦